Company intelligence / Profile preview

MIMS

Ownership: Private
Employees: ~1250
Development stage: Other

Overview

MIMS is Asia-Pacific’s leading multi-channel provider of trusted medical information, education, and knowledge services. It is best known for its comprehensive drug directory and digital platforms that support healthcare professionals’ clinical decision-making. The company does not develop therapeutics or have a clinical pipeline but provides essential resources to improve patient outcomes through information dissemination[1][3][4].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaborates with pharmaceutical companies and healthcare institutions across Asia-Pacific

Beyond the preview

Go deeper on MIMS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIMS.

Explore the full profile